Temi della conferenza Faced with many regulatory bottlenecks, the European cell therapy community must unite and confront these challenges head-on. The 3rd Cell Therapy Analytical Development Summit Europe is your unmissable opportunity to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA.
Speakers: Alison Caldwell, Group Lead, Analytical Development, Resolution Therapeutics, Amanda Versteilen, Associate Director Analytical QC, Bristol Myers Squibb, and more
